MedAssets Revenue and Competitors
Estimated Revenue & Valuation
- MedAssets's estimated annual revenue is currently $418.8M per year.
- MedAssets's estimated revenue per employee is $378,000
Employee Data
- MedAssets has 1108 Employees.
- MedAssets grew their employee count by -2% last year.
MedAssets's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Corporate Security | Reveal Email/Phone |
MedAssets Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17M | 70 | 3% | N/A | N/A |
#2 | $36.5M | 135 | 15% | N/A | N/A |
#3 | $0.1M | 1 | 0% | N/A | N/A |
#4 | $17.3M | 71 | 6% | N/A | N/A |
#5 | $25.7M | 95 | 17% | N/A | N/A |
#6 | $13.4M | 55 | 0% | N/A | N/A |
#7 | $23M | 85 | 0% | N/A | N/A |
#8 | $49.3M | 166 | 7% | N/A | N/A |
#9 | $42.8M | 144 | 7% | N/A | N/A |
#10 | $6.7M | 31 | 3% | N/A | N/A |
What Is MedAssets?
MedAssets is a healthcare performance improvement company that combines strategic market insight with rapid operational execution to help providers sustainably serve the needs of their communities. More than 4,500 hospitals and 123,000 non-acute providers rely on our solutions to reduce the total cost of care, enhance operational efficiency, align clinical delivery and improve revenue performance across the System of CARE. For more information, please visit www.medassets.com. As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets spend and clinical resource management segment from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.
keywords:N/AN/A
Total Funding
1108
Number of Employees
$418.8M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $271.7M | 1109 | 5% | N/A |
#2 | $523.6M | 1165 | 1% | N/A |
#3 | $273.8M | 1349 | N/A | N/A |
#4 | $570.4M | 1509 | 9% | N/A |
#5 | $736.2M | 1767 | 9% | N/A |